Beamtree Holdings
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 2 Jan 2026
- Reported shorts
- 1.6K
- Shares on issue
- 290.597M
Beamtree Holdings (BMT) Short Interest
Beamtree Holdings (ASX:BMT) had 0.00% of shares reported as short positions as of 2 Jan 2026, representing 1,556 shares. Beamtree Holdings operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Beamtree Holdings
Beamtree Holdings provides a proprietary subscription-based Clinical Decision Support system designed to assist health professionals in clinical decision-making tasks. The company leverages advanced technology to improve patient outcomes and streamline healthcare processes, positioning itself as a leader in healthcare innovation.
Company profile →Beamtree Holdings (ASX:BMT) has 0.00% of its shares on issue reported as short positions as of 2 Jan 2026, or about 1,556 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. BMT is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads BMT today
- Zanger BreakoutNot a candidate
- CAN SLIMNot a candidate
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutNot a candidate
- Quality compoundersWatchScore 7rank 1590 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
BMT fundamentals
In the year to 30 Jun 2026, Beamtree Holdings (ASX:BMT) recorded revenue of A$29.2M and a net loss after tax of A$18.3M. A year earlier it recorded revenue of A$28.6M and a net loss after tax of A$6.2M. Year-on-year growth: revenue +2.3% (FY). Net margin −62.5% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest BMT news
All news- Notification of cessation of securities - BMT
asx · 5 Oct 2026
- Beamtree (ASX:BMT): Healthcare AI, Clinical Data and the Path to a More Focused Software Model - Kalkine
googlenews · 8 Sept 2026
- Change of Director's Interest Notice - M Hill
asx · 2 Sept 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss BMT
Start a research thread or post the first pulse update